Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal ...

Globus Medical has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. Globus Medical ( NYSE:GMED – Get Free Report ) last posted its earnings results on Thursday, February 20th.

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

(MENAFN- GlobeNewsWire - Nasdaq) AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of ...